These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3561097)

  • 21. Advances in vaccination against tick-borne encephalitis.
    Rendi-Wagner P
    Expert Rev Vaccines; 2008 Jul; 7(5):589-96. PubMed ID: 18564014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficiency of coadministration of immunomodulators and vaccine in an experiment on tick-borne encephalitis].
    Barinskiĭ IF; Lazarenko AA; Alimbarova LM; Davydova AA
    Vopr Virusol; 2011; 56(4):45-7. PubMed ID: 21899071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys.
    Rumyantsev AA; Chanock RM; Murphy BR; Pletnev AG
    Vaccine; 2006 Jan; 24(2):133-43. PubMed ID: 16115704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination.
    Kleiter I; Jilg W; Bogdahn U; Steinbrecher A
    Infection; 2007 Feb; 35(1):26-9. PubMed ID: 17297586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
    Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms.
    Aberle JH; Aberle SW; Allison SL; Stiasny K; Ecker M; Mandl CW; Berger R; Heinz FX
    J Immunol; 1999 Dec; 163(12):6756-61. PubMed ID: 10586074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigenic relationships between an isolate of the Western Subtype of tick-borne encephalitis virus and an inactivated vaccine derived from it.
    Lee JM; Stephenson JR
    Vaccine; 1985 Sep; 3(3):292-6. PubMed ID: 2998112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model.
    Mandl CW; Aberle JH; Aberle SW; Holzmann H; Allison SL; Heinz FX
    Nat Med; 1998 Dec; 4(12):1438-40. PubMed ID: 9846585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study of the viremia in tick-borne encephalitis in immune and nonimmune animals].
    Barinskii IF; Davydova AA; Karpovich LG; Bukovskaia SN
    Vopr Virusol; 1981; (4):434-8. PubMed ID: 7303628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of purification and inactivation of brain tissue culture preparations of tick-borne encephalitis virus on its antigenic and immunogenic components].
    Nawrocka E; Bednarz K
    Med Dosw Mikrobiol; 1980; 32(1):43-53. PubMed ID: 7412444
    [No Abstract]   [Full Text] [Related]  

  • 32. [Donor immunization with an inactivated concentrated purified vaccine against tick-borne encephalitis to obtain immune blood preparations].
    El'bert LB; Pervikov IuV; Grachev VP; Rusanov VM; Krokhina MA
    Vopr Virusol; 1984; 29(1):56-9. PubMed ID: 6608828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination against tick-borne encephalitis--distant evaluation.
    Bobrowska E; Grzeszczuk A; Prokopowicz D
    Rocz Akad Med Bialymst; 1996; 41(1):44-50. PubMed ID: 8673804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis.
    Pripuzova NS; Tereshkina NV; Gmyl LV; Dzhivanyan TI; Rumyantsev AA; Romanova LIu; Mustafina AN; Lashkevich VA; Karganova GG
    J Med Virol; 2009 Oct; 81(10):1777-85. PubMed ID: 19697399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule.
    Schöndorf I; Beran J; Cizkova D; Lesna V; Banzhoff A; Zent O
    Vaccine; 2007 Feb; 25(8):1470-5. PubMed ID: 17196713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A comparison of the protective properties of preparations of the virion and nonvirion ("soluble") antigens of the tick-borne encephalitis virus].
    Liapustin VN; Pivanova GP; Karavanov AS; Lashkevich VA
    Vopr Virusol; 1991; 36(6):498-500. PubMed ID: 1785186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity and protective efficacy in mice of a formaldehyde-inactivated Indian strain of Japanese encephalitis virus grown in Vero cells.
    Appaiahgari MB; Vrati S
    Vaccine; 2004 Sep; 22(27-28):3669-75. PubMed ID: 15315846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of direct solid-phase immunoenzyme analysis for assessing the immunological activity of a vaccine against tick-borne encephalitis].
    Timofeev AV; El'bert LB; Terletskaia EN; Mal'dov DG; Karavanov AS
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Sep; (9):89-93. PubMed ID: 3318250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Isolation of split and whole-virion tick-borne encephalitis vaccines in an experiment and the characteristics of their immunogenic and antigenic properties].
    Osipova EG; Solianik RG; Fedorov IuV; Tymchishin PN
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):50-3. PubMed ID: 3687295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humoral antibody response in volunteers given the live, highly attenuated "14" clone derived from Langat E5 virus.
    Mayer V
    Acta Virol; 1973 Jul; 17(4):367. PubMed ID: 4148224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.